New strategies are needed to rethink how we treat glaucoma to do more than just manage eye pressure—to actually restore vision by promoting the survival of retinal ganglion cells and their axons.
David J. Calkins, PhD
Advertisement
David J. Calkins, PhD, is Assistant Vice President for Research at Vanderbilt University Medical Center and Chair of the Glaucoma Research Foundation Research Committee and the Catalyst for a Cure Advisory Board.
Articles by David J. Calkins, PhD
Advertisement
Latest Updated Articles
Restoring vision in glaucoma: more than meets the eyePublished: July 13th 2021 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
STAAR and Broadwood conflict over proposed Alcon merger continues
2
FDA clears IND for Complement Therapeutics’ CTx001 gene therapy in geographic atrophy
3
Finding your fit: Excimer lasers and early surgical practice
4
Ocular surface: Targeted therapies for a multifactorial problem
5
.png "Optometry Times"){kind=logo}
